October 17, 2017
HRSA has finalized its proposal to delay enforcement of its final rule imposing civil monetary penalties (CMPs) on manufacturers that overcharge 340B program covered entities until July 1, 2018.[1]Â The rule, which [...]
July 17, 2017
The Centers for Medicare and Medicaid Services (CMS) is poised to propose massive cuts to Medicare Part B reimbursement rates for hospitals and hospital-based grantees participating in the federal 340B drug discount [...]
June 8, 2017
All clients participating in the 340B Discount Drug Program (340B program) should watch carefully for state changes to Medicaid reimbursement for drugs. In 2016, the Centers for Medicare and Medicaid Services (CMS) [...]
June 5, 2017
HRSA has announced that its regulations authorizing the imposition of civil monetary penalties (CMPs) on manufacturers that overcharge 340B program covered entities will not take effect until October 1, 2017, at the [...]
June 1, 2017
The Health Resources and Services Administration (HRSA) urges 340B drug discount program covered entities to adequately monitor the program compliance of their contract pharmacy partners.[1]Â We recently learned that HRSA is sending [...]
January 6, 2017
On January 5, 2017, the Health Resources and Services Administration within the Department of Health and Human Services (HHS) finalized a rule on how the 340B Drug Program sets ceiling prices for 340B [...]
September 2, 2016
On August 12, 2016, a Notice of Proposed Rulemaking (NPRM) titled, “340B Drug Pricing Administrative Dispute Resolution” was published in the Federal Register.The purpose of the proposed rule is to help Covered Entities [...]
February 25, 2016
340B audits are on the rise while at the same time audit procedures are in flux. The Office of Pharmacy Affairs (OPA) at the Health Resources & Services Administration (HRSA) oversees the 340B [...]
September 9, 2015
On August 28, 2015, the Health Resources and Services Administration (HRSA), which administers 340B Drug Pricing Program, released long-awaited proposed guidance (“Guidance”). The purpose of the Guidance is to assist 340B covered entities [...]
-
August 28, 2015
Today the Health Resources and Services Administration (HRSA) released guidance for covered entities enrolled in the 340B Drug Pricing Program (340B Program) and for drug manufacturers that participate in the 340B Program. The [...]
